ACE and benign prostatic hyperplasia: Actually, the BP response to chronic ICV infusion of losartan is more consistent with the effect of peripheral RAS blockade in BPH/2J mice, previously determined using the ACE inhibitor enalaprilat which does not readily cross the BBB (Jackson et al., 2013).